Unlike other ferroptosis inducers, erastin can trigger multiple molecules, including system Xc−, VDAC, and p53, to kill cancer cells efficiently, suggesting a promising future in tumor therapeutic strategies [39]. This evidence concerns the gene TP53 and cancer.